Literature DB >> 28737011

A distinctive patchy osteomalacia characterises Phospho1-deficient mice.

Alan Boyde1, Katherine A Staines2, Behzad Javaheri3, Jose Luis Millan4, Andrew A Pitsillides3, Colin Farquharson2.   

Abstract

The phosphatase PHOSPHO1 is involved in the initiation of biomineralisation. Bones in Phospho1 knockout (KO) mice show histological osteomalacia with frequent bowing of long bones and spontaneous fractures: they contain less mineral, with smaller mineral crystals. However, the consequences of Phospho1 ablation on the microscale structure of bone are not yet fully elucidated. Tibias and femurs obtained from wild-type and Phospho1 null (KO) mice (25-32 weeks old) were embedded in PMMA, cut and polished to produce near longitudinal sections. Block surfaces were studied using 20 kV backscattered-electron (BSE) imaging, and again after iodine staining to reveal non-mineralised matrix and cellular components. For 3D characterisation, we used X-ray micro-tomography. Bones opened with carbide milling tools to expose endosteal surfaces were macerated using an alkaline bacterial pronase enzyme detergent, 5% hydrogen peroxide and 7% sodium hypochlorite solutions to produce 3D surfaces for study with 3D BSE scanning electron microscopy (SEM). Extensive regions of both compact cortical and trabecular bone matrix in Phospho1 KO mice contained no significant mineral and/or showed arrested mineralisation fronts, characterised by a failure in the fusion of the calcospherite-like, separately mineralising, individual micro-volumes within bone. Osteoclastic resorption of the uncalcified matrix in Phospho1 KO mice was attenuated compared with surrounding normally mineralised bone. The extent and position of this aberrant biomineralisation varied considerably between animals, contralateral limbs and anatomical sites. The most frequent manifestation lay, however, in the nearly complete failure of mineralisation in the bone surrounding the numerous transverse blood vessel canals in the cortices. In conclusion, SEM disclosed defective mineralising fronts and extensive patchy osteomalacia, which has previously not been recognised. These data further confirm the role of this phosphatase in physiological skeletal mineralisation.
© 2017 Anatomical Society.

Entities:  

Keywords:  PHOSPHO1; backscattered-electron imaging; biomineralisation; osteoid; osteomalacia

Mesh:

Substances:

Year:  2017        PMID: 28737011      PMCID: PMC5522900          DOI: 10.1111/joa.12628

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  38 in total

1.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.

Authors:  Susan A Steitz; Mei Y Speer; Marc D McKee; Lucy Liaw; Manuela Almeida; Hsueh Yang; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  A study of the post-natal growth and remodeling of bone.

Authors:  D H ENLOW
Journal:  Am J Anat       Date:  1962-03

3.  The presence of PHOSPHO1 in matrix vesicles and its developmental expression prior to skeletal mineralization.

Authors:  Alan J Stewart; Scott J Roberts; Elaine Seawright; Megan G Davey; Robert H Fleming; Colin Farquharson
Journal:  Bone       Date:  2006-07-11       Impact factor: 4.398

4.  PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage.

Authors:  Brian Houston; Alan J Stewart; Colin Farquharson
Journal:  Bone       Date:  2004-04       Impact factor: 4.398

5.  Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities.

Authors:  Scott J Roberts; Alan J Stewart; Peter J Sadler; Colin Farquharson
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

Review 6.  Biomineralization in humans: making the hard choices in life.

Authors:  Kazuhiko Kawasaki; Anne V Buchanan; Kenneth M Weiss
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

7.  Matrix mineralization as a trigger for osteocyte maturation.

Authors:  Kazuharu Irie; Sadakazu Ejiri; Yasunori Sakakura; Toru Shibui; Toshihiko Yajima
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

8.  Comparative modelling of human PHOSPHO1 reveals a new group of phosphatases within the haloacid dehalogenase superfamily.

Authors:  Alan J Stewart; Ralf Schmid; Claudia A Blindauer; Stephen J Paisey; Colin Farquharson
Journal:  Protein Eng       Date:  2003-12

9.  Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization.

Authors:  Scott Roberts; Sonoko Narisawa; Dympna Harmey; José Luis Millán; Colin Farquharson
Journal:  J Bone Miner Res       Date:  2007-04       Impact factor: 6.741

10.  Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.

Authors:  Mei Y Speer; Marc D McKee; Robert E Guldberg; Lucy Liaw; Hsueh-Ying Yang; Elyse Tung; Gerard Karsenty; Cecilia M Giachelli
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  7 in total

Review 1.  Between a rock and a hard place: Regulation of mineralization in the periodontium.

Authors:  Natalie L Andras; Fatma F Mohamed; Emily Y Chu; Brian L Foster
Journal:  Genesis       Date:  2022-04-23       Impact factor: 2.389

2.  50 years of scanning electron microscopy of bone-a comprehensive overview of the important discoveries made and insights gained into bone material properties in health, disease, and taphonomy.

Authors:  Furqan A Shah; Krisztina Ruscsák; Anders Palmquist
Journal:  Bone Res       Date:  2019-05-22       Impact factor: 13.567

Review 3.  Matrix Vesicle-Mediated Mineralization and Osteocytic Regulation of Bone Mineralization.

Authors:  Tomoka Hasegawa; Hiromi Hongo; Tomomaya Yamamoto; Miki Abe; Hirona Yoshino; Mai Haraguchi-Kitakamae; Hotaka Ishizu; Tomohiro Shimizu; Norimasa Iwasaki; Norio Amizuka
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

4.  Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy.

Authors:  Shun-Neng Hsu; Louise A Stephen; Scott Dillon; Elspeth Milne; Behzad Javaheri; Andrew A Pitsillides; Amanda Novak; Jose Luis Millán; Vicky E MacRae; Katherine A Staines; Colin Farquharson
Journal:  J Endocrinol       Date:  2022-08-12       Impact factor: 4.669

5.  Perspective on Dentoalveolar Manifestations Resulting From PHOSPHO1 Loss-of-Function: A Form of Pseudohypophosphatasia?

Authors:  Fatma F Mohamed; Michael B Chavez; Flavia Amadeu de Oliveira; Sonoko Narisawa; Colin Farquharson; José Luis Millán; Brian L Foster
Journal:  Front Dent Med       Date:  2022-02-03

6.  PHOSPHO1 is a skeletal regulator of insulin resistance and obesity.

Authors:  Karla J Suchacki; Nicholas M Morton; Calvin Vary; Carmen Huesa; Manisha C Yadav; Benjamin J Thomas; Sophie Turban; Lutz Bunger; Derek Ball; Martin E Barrios-Llerena; Anyonya R Guntur; Zohreh Khavandgar; William P Cawthorn; Mathieu Ferron; Gérard Karsenty; Monzur Murshed; Clifford J Rosen; Vicky E MacRae; Jose Luis Millán; Colin Farquharson
Journal:  BMC Biol       Date:  2020-10-22       Impact factor: 7.431

7.  Ablation of Enpp6 Results in Transient Bone Hypomineralization.

Authors:  Scott Dillon; Karla Suchacki; Shun-Neng Hsu; Louise A Stephen; Rongling Wang; William P Cawthorn; Alan J Stewart; Fabio Nudelman; Nicholas M Morton; Colin Farquharson
Journal:  JBMR Plus       Date:  2020-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.